Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway

Tumour growth depends on a continual supply of the nutrients and oxygen, which are offered by tumour angiogenesis. Our previous study showed that dipalmitoylphosphatidic acid (DPPA), a bioactive phospholipid, inhibits the growth of triple‐negative breast cancer cells. However, its direct effect on a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian, Zhou, Zijun, Yao, Yuying, Dai, Jianwei, Zhou, Dalei, Wang, Lijing, Zhang, Qian‐Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156235/
https://www.ncbi.nlm.nih.gov/pubmed/30010249
http://dx.doi.org/10.1111/jcmm.13727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156235/
https://www.ncbi.nlm.nih.gov/pubmed/30010249
http://dx.doi.org/10.1111/jcmm.13727

Ejemplares similares